- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07352592
Process-Based Approach Case Series For Anxiety Problems (PBT)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Participants will self-refer to this study by emailing a research assistant (Mr. Whittington).
They will then attend a screening session where they complete an informed consent form and are assessed for inclusion/exclusion criteria. During the screening the research assistant will conduct a clinical interview and collaboratively identify hypothetical processes (e.g. avoidance) that might be contributing to the participants anxiety symptoms. Together, they will identify 8-items from the process-based assessment tool (see survey) that might be relevant to the participants anxiety.
Participants will then complete a baseline survey battery on a lab computer (via Qualtrics; ~20 minutes).
Participants will then complete a two-week assessment period where they complete brief (<2 minute) surveys five times a day (approximately 9 am, noon, 2 pm, 5 pm, and 8 pm) each day for the two weeks. These surveys will be sent to participants' phone via Qualtrics. These surveys will be the 8-items identified during the intake session, with one additional item assessing momentary anxiety and an additional item assessed momentary quality of life perception.
The research team will use the data gathered during the two-week assessment period to create personalized networks of processes leading to participant anxiety symptoms. Each participants' network will guide their therapy treatment.
Participants will then attend up to 25 sessions of counseling for their anxiety. Sessions will occur roughly weekly and will last approximately 50 minutes. All sessions will occur in Dr. Borgogna's lab and clinic space (Campbell Hall Ste 310) on the UAB campus. The therapists in the study will all be masters-level clinicians in the UAB medical/clinical psychology program preparing for licensure (Mr. Whittington, Mr. Johnson, and Ms. Jafari) or a licensed clinical psychologist (Dr. Borgogna). Therapy sessions for pre-licensed clinicians will be recorded onto a UAB computer in Dr. Borgogna's lab and reviewed for supervision purposes by Dr. Borgogna (A/V recordings not for research purposes). Recordings will be deleted within 30 days of each therapy session.
Participants will complete the main battery again at post-test.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Damion D Whittinton, MS
- Phone Number: (205) 934-3850
- Email: whitdrew@uab.edu
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Score on GAD-7 >10 at baseline
- Access to mobile device
Exclusion Criteria:
- Current psychotherapy treatment
- Current/past severe psychopathology (e.g., history of psychosis, suicide attempt or self-injury within the past 12 months, narcotics use within the past 3 months)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Process-based approach
PBA therapy
|
Process-Based Approaches (PBA) were developed to improve psychotherapy outcomes.
Early writings referred to PBA as process-based therapy or process-based cognitive behavioral therapy.
The current nomenclature was adopted to distinguish PBA as a unifying approach that incrementally builds on clinical psychological science rather than a manualized treatment protocol.
PBA provides a framework for flexibly applying evidence-based techniques from multiple therapeutic traditions to target hypothesized psychological processes that give rise to individual patient presentations.
Each patient is conceptualized independently, and intervention structure may vary substantially based on need, while retaining empirically supported tools.
This contrasts with disorder-specific treatment manuals, which assume homogeneity despite substantial variability in underlying processes (e.g., anxiety).
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Generalized Anxiety Disorder-7
Time Frame: From enrollment to the end of treatment, up to 25 weeks.
|
Anxiety scale
|
From enrollment to the end of treatment, up to 25 weeks.
|
|
Beck Anxiety Inventory
Time Frame: From enrollment to the end of treatment, up to 25 weeks.
|
Anxiety Measure
|
From enrollment to the end of treatment, up to 25 weeks.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Patient Health Questionnaire-9
Time Frame: From enrollment to the end of treatment, up to 25 weeks.
|
Depression measure
|
From enrollment to the end of treatment, up to 25 weeks.
|
|
Experiential Avoidance Rating Scale
Time Frame: From enrollment to the end of treatment, up to 25 weeks.
|
Experiential avoidance measure
|
From enrollment to the end of treatment, up to 25 weeks.
|
|
Quality of Life Scale
Time Frame: From enrollment to the end of treatment, up to 25 weeks.
|
Quality of Life Measure
|
From enrollment to the end of treatment, up to 25 weeks.
|
|
Big Five Inventory
Time Frame: From enrollment to the end of treatment, up to 25 weeks.
|
Measure of Personality
|
From enrollment to the end of treatment, up to 25 weeks.
|
|
PSY-Flex
Time Frame: From enrollment to the end of treatment, up to 25 weeks.
|
Psychological flexibility measure
|
From enrollment to the end of treatment, up to 25 weeks.
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Process-based assessment tool
Time Frame: Five times a day for two weeks prior to intervention
|
A collection of hypothetical processes that might be correlated with mental illness outcomes.
Selections will be used to inform patient conceptualizations prior to therapy.
|
Five times a day for two weeks prior to intervention
|
Collaborators and Investigators
Investigators
- Principal Investigator: Nicholas C Borgogna, PhD, University of Alabama at Birmingham
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- UAB PBT
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- ICF
- ANALYTIC_CODE
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Anxiety
-
University of CalabriaNot yet recruitingAnxiety | Anxiety Disease | Anxiety and Distress | Public Speaking AnxietyItaly
-
Clinica Alemana de SantiagoUniversidad del DesarrolloRecruitingAnxiety | Induction of Anesthesia | Anxiety Preoperative | Technology Use | Child Anxiety | Anesthesia Care | Anxiety After SurgeryChile
-
Boston Medical CenterPatient-Centered Outcomes Research Institute; Boston University; Johns Hopkins... and other collaboratorsCompletedAnxiety Disorders | Anxiety | Anxiety Symptoms | Child Anxiety | Anxiety, Mild to Moderate | Pediatric Anxiety DisordersUnited States
-
Yale UniversityNational Institute of Mental Health (NIMH)CompletedGeneralized Anxiety Disorder | Anxiety Disorder of Childhood | Separation Anxiety Disorder of Childhood | Social Anxiety Disorder of ChildhoodUnited States
-
AstraZenecaCompletedAnxiety Disorders | Anxiety | Anxiety Neuroses | Anxiety StatesUnited States
-
Ann & Robert H Lurie Children's Hospital of ChicagoUniversity of California, Los Angeles; University of CincinnatiActive, not recruitingAnxiety, Separation | Anxiety, Social | Anxiety, GeneralizedUnited States
-
Abant Izzet Baysal UniversityRecruitingAnxiety | Parental AnxietyTurkey (Türkiye)
-
Florida State UniversityRecruitingAnxiety | Generalized Anxiety Disorder (GAD) | WorryingUnited States
-
Institut National de la Santé Et de la Recherche...Active, not recruitingAnxiety Disorders | Anxiety | Anxiety and FearFrance
-
Prisma Health-UpstateCompletedAnxiety | Anxiety, Separation | Separation Anxiety | Anxiety Generalized
Clinical Trials on Process-Based Approach
-
TC Erciyes UniversityRecruitingHemodialytic PatientsTurkey
-
TC Erciyes UniversityNot yet recruiting
-
Western UniversityRecruitingDiabetes Mellitus, Type 2 | Sedentary Behavior | Adult ALLCanada
-
Queen Mary University of LondonRecruiting
-
Boston University Charles River CampusTerminated
-
Nationwide Children's HospitalCompletedPatellofemoral Pain SyndromeUnited States
-
General University Hospital, PragueKarolinska Institutet; Medical University of Vienna; Aarhus University Hospital; Heinrich-Heine University, Duesseldorf and other collaboratorsNot yet recruitingExtracorporeal Membrane Oxygenation | Ventricular Fibrillation | Cardiac Arrest | Out-Of-Hospital Cardiac Arrest | Sudden Cardiac Arrest | Extracorporeal Cardiopulmonary Resuscitation
-
Mashhad University of Medical SciencesUnknownCompetenceIran, Islamic Republic of
-
Saglik Bilimleri UniversitesiCompleted
-
Yale UniversityCompletedElectronic Fetal MonitoringUnited States